Journal Article

Protective reactive thymus hyperplasia in COVID-19 acute respiratory distress syndrome

Couëdel-Courteille, Anne, Dutrieux, Jacques, Naudin, Cécile, Squara, Pierre, Marullo, Stefano, Cheynier, Rémi, Roux, Hélène, Charmeteau de Muylder, Bénédicte, Cuvelier, Pelagia

2021

Overview

Background Patients with COVID-19 (COVID) may develop acute respiratory distress syndrome with or without sepsis, coagulopathy and visceral damage. While chest CT scans are routinely performed in the initial assessment of patients with severe pulmonary forms, thymus involvement and reactivation have not been investigated so far. Methods In this observational study, we systematically scored the enlargement of the thymus and the lung involvement, using CT scans, in all adult patients admitted to the ICU for COVID or any other cause (control group) at one centre between March and April 2020. Initial biological investigations included nasal detection of SARS-CoV-2 ribonucleic acid by polymerase chain reaction (PCR). In a subgroup of 24 patients with different degrees of pulmonary involvement and thymus hypertrophy, plasma cytokine concentrations were measured and the export of mature T cells from the thymus was estimated simultaneously by PCR quantification of T cell receptor excision circles (TRECs). Results Eighty-seven patients were studied: 50 COVID patients and 37 controls. Non-atrophic or enlarged thymus was more commonly observed in COVID patients than in controls (66% vs. 24%, p  < 0.0001). Thymus enlargement in COVID patients was associated with more extensive lung injury score on CT scans (4 [3–5] vs. 2 [1.5–4], p  = 0.01), but a lower mortality rate (8.6% vs. 41.2%, p  < 0.001). Other factors associated with mortality were age, lymphopaenia, high CRP and co-morbidities. COVID patients had higher concentrations of IL-7 (6.00 [3.72–9.25] vs. 2.17 [1.76–4.4] pg/mL; p  = 0.04) and higher thymic production of new lymphocytes (sj/βTREC ratio = 2.88 [1.98–4.51] vs. 0.23 [0.15–0.60]; p  = 0.004). Thymic production was also correlated with the CT scan thymic score ( r  = 0.38, p  = 0.03) and inversely correlated with the number of lymphocytes ( r  = 0.56, p  = 0.007). Conclusion In COVID patients, thymus enlargement was frequent and associated with increased T lymphocyte production, which appears to be a beneficial adaptation to virus-induced lymphopaenia. The lack of thymic activity/reactivation in older SARS-CoV-2 infected patients could contribute to a worse prognosis.

• Publisher: BioMed Central,BioMed Central Ltd,Springer Nature B.V,BMC
• Subject: Acute respiratory distress syndrome / Adults / Age / Aged / Case-Control Studies / Complications and side effects / Coronaviruses / COVID-19 / COVID-19 - complications / Critical care / Critical Care Medicine / Cytokines / Development and progression / Emergency Medicine / Endocrine gland diseases / Female / Health aspects / Hospitalization / Humans / Hyperplasia / Infections / Intensive / Intensive care / Intensive Care Units / Laboratories / Life Sciences / Lymphocytes / Male / Medical imaging / Medicine / Medicine & Public Health / Middle Aged / Older people / Patient outcomes / Respiratory diseases / Respiratory Distress Syndrome - virology / Severe acute respiratory syndrome coronavirus 2 / Statistical analysis / T cell receptors / Thorax - diagnostic imaging / Thymus / Thymus gland / Thymus Hyperplasia - diagnostic imaging / Thymus Hyperplasia - virology / Thymus reactivation / Tomography, X-Ray Computed / TREC